128 related articles for article (PubMed ID: 35771679)
1. The Efficacy of Golimumab Against Non-Infectious Uveitis: A PRISMA-Compliant Systematic Review and Meta-Analysis.
Okada K; Zhou Y; Hashida N; Takagi T; Tian YS
Ocul Immunol Inflamm; 2023 Jul; 31(5):1013-1023. PubMed ID: 35771679
[TBL] [Abstract][Full Text] [Related]
2. Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease.
Fabiani C; Sota J; Rigante D; Vitale A; Emmi G; Vannozzi L; Franceschini R; Bacherini D; Frediani B; Galeazzi M; Tosi GM; Cantarini L
Ocul Immunol Inflamm; 2019; 27(1):58-63. PubMed ID: 28981395
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of golimumab in patients with refractory non-infectious panuveitis.
Tungsattayathitthan U; Tesavibul N; Choopong P; Treeratsakulchai C; Ngathaweesuk Y; Sanphan W; Boonsopon S
Sci Rep; 2024 Jan; 14(1):2179. PubMed ID: 38273077
[TBL] [Abstract][Full Text] [Related]
4. mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol.
Blair J; Barry R; Murray PI; Moore DJ; Denniston AK
Syst Rev; 2018 Jun; 7(1):83. PubMed ID: 29885659
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of TNF inhibitor (golimumab) as salvage treatment in patients with refractory noninfectious uveitis.
Jin Y; Lu S; Lin Y; Mou X
Inflammopharmacology; 2022 Aug; 30(4):1363-1368. PubMed ID: 35802282
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.
Tosi GM; Sota J; Vitale A; Rigante D; Emmi G; Lopalco G; Guerriero S; Orlando I; Iannone F; Frediani B; Angotti R; Messina M; Galeazzi M; Vannozzi L; Cantarini L; Fabiani C
Clin Exp Rheumatol; 2019; 37(4):680-683. PubMed ID: 30943133
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in adults.
Borrás-Blasco J; Casterá DE; Cortes X; Abad FJ; Rosique-Robles JD; Mallench LG
Int J Clin Pharmacol Ther; 2015 May; 53(5):377-90. PubMed ID: 25345430
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal dexamethasone implants for non-infectious uveitis.
McCartney M; McCluskey P; Zagora S
Clin Exp Ophthalmol; 2019 Dec; 47(9):1156-1163. PubMed ID: 31412151
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.
Barry RJ; Tallouzi MO; Bucknall N; Mathers JM; Murray PI; Calvert MJ; Moore DJ; Denniston AK
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012577. PubMed ID: 30562409
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
[TBL] [Abstract][Full Text] [Related]
11. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771
[TBL] [Abstract][Full Text] [Related]
12. Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis.
Liu W; Bai D; Kou L
BMC Ophthalmol; 2023 May; 23(1):240. PubMed ID: 37248486
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol.
Tallouzi MO; Moore DJ; Calvert M; Murray PI; Bucknall N; Denniston AK
Syst Rev; 2016 Feb; 5():29. PubMed ID: 26872918
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis.
Yazgan S; Celik U; Işık M; Yeşil NK; Baki AE; Şahin H; Gencer E; Doğan İ
Int Ophthalmol; 2017 Feb; 37(1):139-145. PubMed ID: 27154720
[TBL] [Abstract][Full Text] [Related]
15. Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients.
Calvo-Río V; Blanco R; Santos-Gómez M; Rubio-Romero E; Cordero-Coma M; Gallego-Flores A; Veroz R; Torre I; Hernández FF; Atanes A; Loricera J; González-Vela MC; Palmou N; Hernández JL; González-Gay MA
Semin Arthritis Rheum; 2016 Aug; 46(1):95-101. PubMed ID: 27060872
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal injection versus systematic treatment in patients with uveitis undergoing cataract surgery: a systematic review and meta-analysis.
Hsieh YH; Jhou HJ; Chen PH; Hwang YS
Graefes Arch Clin Exp Ophthalmol; 2023 Mar; 261(3):809-820. PubMed ID: 36271933
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of treatment with sirolimus for non-infectious uveitis: a meta-analysis and systematic review.
Cabahug VLO; Uy HS; Yu-Keh E; Sapno KJD
Clin Ophthalmol; 2019; 13():649-669. PubMed ID: 31114144
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment with golimumab for severe uveitis.
Miserocchi E; Modorati G; Pontikaki I; Meroni PL; Gerloni V
Ocul Immunol Inflamm; 2014 Apr; 22(2):90-5. PubMed ID: 24143896
[TBL] [Abstract][Full Text] [Related]
19. A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults.
Squires H; Poku E; Bermejo I; Cooper K; Stevens J; Hamilton J; Wong R; Denniston A; Pearce I; Quhill F
Health Technol Assess; 2017 Nov; 21(68):1-170. PubMed ID: 29183563
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review.
Leal I; Rodrigues FB; Sousa DC; Romão VC; Duarte GS; Carreño E; Dick AD; Marques-Neves C; Costa J; Fonseca JE
Acta Ophthalmol; 2018 Sep; 96(6):e665-e675. PubMed ID: 29577629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
